Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOCILIZUMAB Cause Hepatic enzyme increased? 7,691 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 7,691 reports of Hepatic enzyme increased have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 7.8% of all adverse event reports for TOCILIZUMAB.

7,691
Reports of Hepatic enzyme increased with TOCILIZUMAB
7.8%
of all TOCILIZUMAB reports
2,026
Deaths
2,765
Hospitalizations

How Dangerous Is Hepatic enzyme increased From TOCILIZUMAB?

Of the 7,691 reports, 2,026 (26.3%) resulted in death, 2,765 (36.0%) required hospitalization, and 2,037 (26.5%) were considered life-threatening.

Is Hepatic enzyme increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 7,691 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Hepatic enzyme increased?

METHOTREXATE (9,857) ADALIMUMAB (8,693) ETANERCEPT (7,481) ABATACEPT (7,397) RITUXIMAB (7,247) LEFLUNOMIDE (7,173) INFLIXIMAB (6,778) HYDROXYCHLOROQUINE (6,555) TOFACITINIB (6,269) PREDNISONE (5,897)

Which TOCILIZUMAB Alternatives Have Lower Hepatic enzyme increased Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

Related Pages

TOCILIZUMAB Full Profile All Hepatic enzyme increased Reports All Drugs Causing Hepatic enzyme increased TOCILIZUMAB Demographics